NICE rejects cabotegravir for PrEP in draft guidance Draft guidance said the HIV pre-exposure prophylaxis (PrEP) treatment cabotegravir is not recommended because “it is not possible to determine the cost-effectiveness estimate ... without further analyses from the manufacturer”.…
Community pharmacies to receive increase in funding worth £13.2m for 2024/2025 Community Pharmacy Scotland has accepted a £13.2m uplift in the country's community pharmacy remuneration global sum, bringing the total to £232.7m for 2024/2025.…
Why I took a ‘workforce wellbeing’ course for pharmacy managers A pharmacy employer shares her experience of taking a course to improve her employees’ wellbeing in light of rising levels of burn out across the profession.…
Call for Society Fellowship nominationsThe Panel of Fellows will be holding its next meeting in November 2024. Nominations for Society Fellowship must be received by the Secretary of the Panel of Fellows by 23 October 2024 to be considered at this meeting. Nominations need to be made by a current member of the Society and supported by…
Triptans should be considered as preferred first-line treatment for acute migraine, research concludes From head-to-head comparisons between active interventions, the meta-analysis showed that eletriptan was the most effective drug for pain freedom at two hours post dose.…
Lipid-lowering therapies for the secondary prevention of cardiovascular disease in primary care An overview of updated guidance relating to the secondary prevention of cardiovascular disease can be applied in practice, considering the availability of newer medications.…
Almost 14,000 temporary pharmacy closures reported across England in 2023, research finds North East and North Cumbria Integrated Care Board recorded the highest number of temporary closures (1,438) and hours lost (4,054).…
Pharmacy teams advised to produce ready-to-administer oxytocin infusions for maternity services Required oxytocin infusions will now need to be prepared at the time of the event, prompting concerns this will add pressure to already stretched maternity services.…
Everything you need to know about the NHS antibiotic subscription model Following what has been deemed a successful pilot, NHS England is hoping that its new subscription model will boost drug development by paying manufacturers a fixed fee for antimicrobials.…
Regulator misses fitness-to-practise timeliness standard for sixth year in a row The Professional Standards Authority said the General Pharmaceutical Council “is still taking too long to progress fitness-to-practise investigations”.…
